Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.6.3925

CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) Polymorphisms and Bladder Cancer Risk in a Turkish Population  

Berber, Ufuk (Pathology Department, Haydarpasa Training Hospital, Gulhane Military Medical Academy)
Yilmaz, Ismail (Pathology Department, Haydarpasa Training Hospital, Gulhane Military Medical Academy)
Yilmaz, Omer (Urology Department, Haydarpasa Training Hospital, Gulhane Military Medical Academy)
Haholu, Aptullah (Pathology Department, Haydarpasa Training Hospital, Gulhane Military Medical Academy)
Kucukodaci, Zafer (Pathology Department, Haydarpasa Training Hospital, Gulhane Military Medical Academy)
Ates, Ferhat (Urology Department, Haydarpasa Training Hospital, Gulhane Military Medical Academy)
Demirel, Dilaver (Pathology Department, Haydarpasa Training Hospital, Gulhane Military Medical Academy)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.6, 2013 , pp. 3925-3929 More about this Journal
Abstract
We aimed to investigate bladder cancer risk with reference to polymorphic variants of cytochrome p450 (CYP) 1A1, CYP1B1, glutathione S-transferase (GST) M1, and GSTT1 genes in a case control study. Polymorphisms were examined in 114 bladder cancer patients and 114 age and sex-matched cancer-free subjects. Genotypes were determined using allele specific PCR for CYP1A1 and CYP1B1 genes, and by multiplex PCR and melting curve analysis for GSTM1 and GSTT1 genes. Our results revealed a statistically significant increased bladder cancer risk for GSTT1 null genotype carriers with an odds ratio of 3.06 (95% confidence interval=1.39-6.74, p=0.006). Differences of CYP1A1, CYP1B1 and GSTM1 genotype frequencies were not statistically significant between patients and controls. However, the specific combination of GSTM1 null, GSTT1 null, and CYP1B1 codon 119 risk allele carriers and specific combination of GSTM1 present, GSTT1 null, and CYP1B1 432 risk allele carriers exhibited increased cancer risk in the combined analysis. We did not observe any association between different genotype groups and prognostic tumor characteristics of bladder cancer. Our results indicate that inherited absence of GSTT1 gene may be associated with bladder cancer susceptibility, and specific combinations of GSTM1, GSTT1 and CYP1B1 gene polymorphisms may modify bladder cancer risk in the Turkish population, without any association being observed for CYP1A1 gene polymorphism and bladder cancer risk.
Keywords
Bladder cancer; CYP1A1; CYP1B1; GSTM1; GSTT1;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Feng Z, Hu W, Rom WN, Beland FA, Tang MS (2002). 4-Aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis, 23, 1721-7.   DOI   ScienceOn
2 Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF (2000). Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res, 60, 3440-4.
3 Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Anttila S, Vainio H (1992). Point-mutational MspI and Ile${\pm}$Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev, 1, 485-9.
4 Ji YN, Wang Q, Suo LJ (2012). CYP1A1 $Ile^{462}Val$polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: A meta-analysis. PLoS ONE, 7, 43397.   DOI
5 Lee KM, Kang D, Clapper ML, et al (2008). CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among asian populations. Cancer Epidemiol Biomarkers Prev, 17, 1120-6.   DOI   ScienceOn
6 Lopez-beltran A, Cheng L, Mazzucchelli R, et al (2008). Morphological and molecular profiles and pathways in bladder neoplasms. Anticancer Res, 28, 2893-900.
7 Pollard C, Smith SC, Theodorescu D (2010). Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC). Expert Rev Mol Med, 12, 10.   DOI   ScienceOn
8 Rebbeck TR, Walker AH, Jaffe JM, et al (1999). Glutathione S-transferase-$\mu$ (GSTM1) and -$\Theta$ (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev, 8, 283-7.
9 Salinas-Sanchez AS, Donate-Moreno MJ, Lopez-Garrido MP, Gimenez-Bachs JM, Escribano J (2012). Role of CYP1B1 gene polymorphisms in bladder cancer cusceptibility. J Urol, 187, 700-6.   DOI   ScienceOn
10 Senthilkumar KP, Thirumurugan R (2012). GSTM1 and GSTT1 allele frequencies among various Indian and non-Indian ethnic groups. Asian Pac J Cancer Prev, 13, 6263-7.   과학기술학회마을   DOI   ScienceOn
11 Sharma A, Pandey A, Sardana S, et al (2012). Genetic polymorphisms of GSTM1 and GSTT1 genes in Delhi and comparison with other Indian and global populations. Asian Pac J Cancer Prev, 13, 5647-52.   과학기술학회마을   DOI   ScienceOn
12 Shukla D, Dinesh KA, Hallikerimath S, Vivekanandhan S, Venkatakanthaiah Y (2012). Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer. Biomedical Papers, 156, 253-9.   DOI   ScienceOn
13 Song DK, Xing DL, Zhang LR, et al (2009). Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in central China. Cancer Detection and Prev, 32, 416-23.   DOI   ScienceOn
14 Tanaka Y, Sasaki M, Kaneuchi M, et al (2002). Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer. Biochem Biophys Res Commun, 296, 820-6.   DOI   ScienceOn
15 Toruner GA, Akyerli C, Ucar A, et al (2001). Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in Turkish population. Arch Toxicol, 75, 459-64.
16 Turesky RJ, Le Marchand L (2011). Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem Res Toxicol, 24, 1169-214.   DOI   ScienceOn
17 Yang CX, Matsuo K, Wang ZM, Tajima K (2005). Phase I/II enzyme gene polymorphisms and esophageal cancer risk: A meta-analysis of the literature. World J Gastroenterol, 11, 2531-8.   DOI
18 Aktas D, Hascicek M, Sozen S, et al (2004). CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Cancer Gene Cytogenet, 154, 81-5.   DOI   ScienceOn
19 Zhou LP, Luan H, Dong XH, et al (2012). Genetic variants of CYP2D6 gene and cancer risk: a HuGE systematic review and meta-analysis. Asian Pac J Cancer Prev, 13, 3165-72.   과학기술학회마을   DOI   ScienceOn
20 Aktas D, Guney I, Alikasifoglu M, et al (2002). CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm. Gynecol Oncol, 86, 124-8.   DOI   ScienceOn
21 Altayli E, Gunes S, Yilmaz AF, Goktas S, Bek Y (2009). CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population. Int Urol Nephrol, 41, 259-66.   DOI
22 Atinkaya C, Taspinar M, Sakiragaoglu S, et al (2012). The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case-control study. Hum Exp Toxicol, 31, 1074-80.   DOI   ScienceOn
23 Bartsch H, Nair U, Risch A, et al (2000). Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev, 9, 3-28.
24 Boffetta P, Jourenkova N, Gustavsson P (1997). Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control, 8, 444-72.   DOI   ScienceOn
25 Botelho MC, Machado JC, da Costa JMC (2010). Schistosoma haematobium and bladder cancer. What lies beneath? Virulence, 1, 84-7.   DOI   ScienceOn
26 Cengiz M, Ozaydin A, Ozkilic AC, Dedekarginoglu G (2007). The investigation of GSTT1, GSTM1 and SOD polymorphism in bladder cancer patients. Int Urol Nephrol, 39, 1043-8.   DOI
27 Dong LM, Potter JD, White E, et al (2008). Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA, 299, 2423-36.   DOI   ScienceOn
28 Fatima M, Garcia N, Munoz X, et al (2010). Simultaneous genotyping of GSTT1 and GSTM1 null polymorphisms by melting curve analysis in presence of SYBR Green I. J Mol Diagn, 12, 300-4.   DOI   ScienceOn